感染新冠后患自身免疫性疾病的风险增加。
High risk of autoimmune diseases after COVID-19.
机构信息
Division Pediatric Cardiology, Willson Heart Center, Valley Children's Healthcare, Madera, CA, USA.
Department of Biological Sciences & Engineering, Indian Institute of Technology Palakkad, Palakkad, India.
出版信息
Nat Rev Rheumatol. 2023 Jul;19(7):399-400. doi: 10.1038/s41584-023-00964-y.
Abstract
The full picture of post-COVID-19 autoimmune diseases and their prevalence is lacking despite numerous case reports and small series. Two studies that use large cohorts now highlight that SARS-CoV-2 infection is linked to a substantially increased risk of developing a diverse spectrum of new-onset autoimmune diseases.
摘要
尽管有许多病例报告和小系列研究，但仍缺乏关于 COVID-19 后自身免疫性疾病及其患病率的全貌。两项使用大样本队列的研究现在强调，SARS-CoV-2 感染与多种新发自身免疫性疾病发生风险显著增加有关。
相似文献
1
High risk of autoimmune diseases after COVID-19.感染新冠后患自身免疫性疾病的风险增加。
Nat Rev Rheumatol. 2023 Jul;19(7):399-400. doi: 10.1038/s41584-023-00964-y.
2
COVID-19 Associated With Higher Risk of Autoimmune Diseases.新冠病毒感染与自身免疫性疾病风险升高相关。
JAMA. 2024 Apr 16;331(15):1266. doi: 10.1001/jama.2024.2092.
3
Incidence and severity of COVID-19 in patients with autoimmune blistering skin diseases: A nationwide study.自身免疫性水疱性皮肤病患者中新冠病毒病的发病率和严重程度：一项全国性研究。
J Am Acad Dermatol. 2022 Feb;86(2):494-497. doi: 10.1016/j.jaad.2021.10.034. Epub 2021 Oct 29.
4
Cutaneous autoimmune diseases during COVID-19 pandemic.新冠疫情期间的皮肤自身免疫性疾病
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e667-e670. doi: 10.1111/jdv.16753. Epub 2020 Jul 2.
5
COVID-19 illness and autoimmune diseases: recent insights.COVID-19 疾病与自身免疫性疾病：最新见解。
Inflamm Res. 2021 Apr;70(4):407-428. doi: 10.1007/s00011-021-01446-1. Epub 2021 Feb 28.
6
Increasing autoimmune rheumatic diseases as a consequence of the COVID-19 pandemic: A hypothesis or fact?2019年冠状病毒病大流行导致自身免疫性风湿性疾病增加：一种假说还是事实？
Int J Rheum Dis. 2024 Jan;27(1):e15011. doi: 10.1111/1756-185X.15011. Epub 2023 Dec 22.
7
COVID-19 and autoimmune bullous diseases: Lessons learned.COVID-19 与自身免疫性大疱性疾病：经验教训。
Autoimmun Rev. 2023 Apr;22(4):103286. doi: 10.1016/j.autrev.2023.103286. Epub 2023 Feb 2.
8
Insights into new-onset autoimmune diseases after COVID-19 vaccination.新冠病毒疫苗接种后新发自身免疫性疾病的研究进展。
Autoimmun Rev. 2023 Jul;22(7):103340. doi: 10.1016/j.autrev.2023.103340. Epub 2023 Apr 17.
9
High incidence of multisystem inflammatory syndrome and other autoimmune diseases after SARS-CoV-2 infection compared to COVID-19 vaccination in children and adolescents in south central Europe.与 COVID-19 疫苗接种相比，在中南欧儿童和青少年中，SARS-CoV-2 感染后的多系统炎症综合征和其他自身免疫性疾病发病率更高。
Clin Exp Rheumatol. 2023 May;41(5):1183-1191. doi: 10.55563/clinexprheumatol/i1l2xn. Epub 2022 Nov 12.
10
Autoimmune complications of COVID-19.新型冠状病毒肺炎的自身免疫并发症
J Med Virol. 2022 Jan;94(1):54-62. doi: 10.1002/jmv.27292. Epub 2021 Aug 31.
引用本文的文献
1
Late-Induced Autoimmune Disorders Post-COVID-19 Vaccination/Infection: Case Report From Iran.新冠疫苗接种/感染后迟发性自身免疫性疾病：来自伊朗的病例报告
Case Rep Med. 2025 Aug 28;2025:8815875. doi: 10.1155/carm/8815875. eCollection 2025.
2
Effectiveness of Japanese traditional medicine (Kamikihito and Saikokeishito) for treating long COVID: a prospective observational study.日本传统医学（加味逍遥汤和柴胡桂枝汤）治疗新冠后长期症状的有效性：一项前瞻性观察研究。
Front Med (Lausanne). 2025 Jul 21;12:1609812. doi: 10.3389/fmed.2025.1609812. eCollection 2025.
3
Pathogenesis of Autoimmunity/Systemic Lupus Erythematosus (SLE).自身免疫/系统性红斑狼疮（SLE）的发病机制
Cells. 2025 Jul 15;14(14):1080. doi: 10.3390/cells14141080.
4
Parental management of autoimmune disease with complementary and alternative medicine: a scoping review of the literature in OECD countries.经合组织国家中父母使用补充和替代医学对自身免疫性疾病的管理：文献综述
BMC Complement Med Ther. 2025 Jul 10;25(1):255. doi: 10.1186/s12906-025-04929-4.
5
Comprehensive transcriptome assessment in PBMCs of post-COVID patients at a median follow-up of 28 months after a mild COVID infection reveals upregulation of JAK/STAT signaling and a prolonged immune response.对轻度新冠感染后中位随访28个月的新冠康复患者外周血单核细胞进行的全面转录组评估显示，JAK/STAT信号上调且免疫反应持续时间延长。
Front Immunol. 2025 May 30;16:1589589. doi: 10.3389/fimmu.2025.1589589. eCollection 2025.
6
Evans Syndrome and COVID-19 Infection or Vaccination: A Systematic Review of Case Reports.伊文斯综合征与新冠病毒感染或疫苗接种：病例报告的系统评价
J Hematol. 2025 Jun;14(3):109-123. doi: 10.14740/jh2058. Epub 2025 May 13.
7
Thyroid disorders and COVID-19: a comprehensive review of literature.甲状腺疾病与2019冠状病毒病：文献综述
Front Endocrinol (Lausanne). 2025 May 19;16:1535169. doi: 10.3389/fendo.2025.1535169. eCollection 2025.
8
9
From infection to autoimmunity: can COVID-19 spark new auto-immune conditions?从感染到自身免疫：新冠病毒会引发新的自身免疫疾病吗？
Respir Med Case Rep. 2025 Apr 26;55:102216. doi: 10.1016/j.rmcr.2025.102216. eCollection 2025.
10
COVID19-Related Onset and Relapses of Juvenile Systemic Lupus Erythematosus-Like Disease.与COVID-19相关的青少年系统性红斑狼疮样疾病的发病和复发
J Paediatr Child Health. 2025 Aug;61(8):1318-1321. doi: 10.1111/jpc.70087. Epub 2025 May 22.
本文引用的文献
1
Incidence of immune-mediated inflammatory diseases following COVID-19: a matched cohort study in UK primary care.新冠病毒感染后免疫介导的炎症性疾病的发病率：英国初级保健中的匹配队列研究。
BMC Med. 2023 Sep 21;21(1):363. doi: 10.1186/s12916-023-03049-5.
2
Risk of autoimmune diseases in patients with COVID-19: A retrospective cohort study.新型冠状病毒肺炎患者患自身免疫性疾病的风险：一项回顾性队列研究。
EClinicalMedicine. 2023 Feb;56:101783. doi: 10.1016/j.eclinm.2022.101783. Epub 2023 Jan 10.
3
An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease.人工智能指导下的特征揭示了 MIS-C 和川崎病中的共同宿主免疫反应。
Nat Commun. 2022 May 16;13(1):2687. doi: 10.1038/s41467-022-30357-w.
4
SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19.新型冠状病毒特异性免疫应答与 COVID-19 发病机制。
Int J Mol Sci. 2022 Feb 2;23(3):1716. doi: 10.3390/ijms23031716.
5
New Onset of Autoimmune Diseases Following COVID-19 Diagnosis.新冠病毒感染后自身免疫性疾病的新发病例。
Cells. 2021 Dec 20;10(12):3592. doi: 10.3390/cells10123592.
6
Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison.儿童多系统炎症综合征与川崎病：关键对比。
Nat Rev Rheumatol. 2021 Dec;17(12):731-748. doi: 10.1038/s41584-021-00709-9. Epub 2021 Oct 29.
7
Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients.系统免疫分析揭示了肺和肺外组织对重症 COVID-19 患者免疫发病机制的贡献。
Front Immunol. 2021 Jun 28;12:595150. doi: 10.3389/fimmu.2021.595150. eCollection 2021.
8
COVID-19 and autoimmune diseases.新型冠状病毒肺炎与自身免疫性疾病。
Curr Opin Rheumatol. 2021 Mar 1;33(2):155-162. doi: 10.1097/BOR.0000000000000776.
9
Virology, Epidemiology, Pathogenesis, and Control of COVID-19.COVID-19 的病毒学、流行病学、发病机制和防控。
Viruses. 2020 Mar 27;12(4):372. doi: 10.3390/v12040372.
Zotero 插件